Drug Shortage Report for ONDANSETRON INJECTION, USP
Report ID | 4083 |
Drug Identification Number | 02390019 |
Brand name | ONDANSETRON INJECTION, USP |
Common or Proper name | Ondansetron |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ONDANSETRON |
Strength(s) | 2MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 2ML 5VL |
ATC code | A04AA |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2017-05-10 |
Actual start date | |
Estimated end date | |
Actual end date | 2017-05-01 |
Shortage status | Avoided shortage |
Updated date | 2017-05-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2017-05-03 | French | Compare |
v4 | 2017-05-03 | English | Compare |
v3 | 2017-05-03 | English | Compare |
v2 | 2017-03-23 | French | Compare |
v1 | 2017-03-23 | English | Compare |
Showing 1 to 5 of 5